FDA lowers starting dose of sleep drug Lunesta, citing safety concerns

May 15, 2014 7:02 PM

30 0

Bottles and pills of Sanofi-Aventis SA’s Ambien, left, the top-selling insomnia drug in the United States, and Sunovion Pharmaceuticals’s Lunesta are arranged in a Cambridge, Mass. pharmacy, Wednesday, March 23, 2006. (JB Reed/Bloomberg News)

The Food and Drug Administration is worried that a sleeping pill you take tonight could make for a riskier drive to work tomorrow.

Read more

To category page